About
Alafair Biosciences, Inc. is a commercial-stage medical device company that specializes in innovative surgical products utilizing proprietary hydrogel technology. The company aims to enhance surgical care by improving soft tissue protection and patient outcomes through advanced biomaterials. The flagship product, the VersaWrap Hydrogel Sheet, is an FDA-cleared, bioresorbable hydrogel made primarily of hyaluronic acid and alginate. It is designed to prevent postsurgical soft-tissue tethering, which can impair movement and cause pain. VersaWrap is available in variants such as the VersaWrap Tendon Protector and VersaWrap Nerve Protector, catering to various soft-tissue surgical procedures. Led by co-founder and Chief Scientific Officer Dr. Sarah Mayes, Alafair has achieved significant commercial growth, with over 24,000 VersaWrap implants distributed nationwide. The company has expanded its distribution network and was recognized by Inc. 5000 as the 11th fastest-growing private company in Health Products. Alafair Biosciences is committed to providing advanced solutions for soft-tissue repair, focusing on quality and clinical value.
Technologies
Keywords
Company Information
-
Employees 48
-
Founded 2011
-
Annual Revenue $4000000
-
Total Funding $20679040
Location
6101 W Courtyard Dr, Austin, Texas, United States, 78730-5001